1604621

Risedronat-verwandte Verbindung A

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): [1-Hydroxy-2-(2-pyridinyl)-ethyliden]-bis-phosphonsäure
• Empirische Formel (Hill-System): C₇H₁₁NO₇P₂
• CAS-Nummer: 105462-23-5
• Molekulargewicht: 283.11
• Beilstein: 8151626
• MDL-Nummer: MFCD26142885
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329751049
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: risedronate
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• SMILES String: OP(O)(C(O)(CC1=NC=CC=C1)P(O)(O)=O)=O
• InChI: 1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)5-6-3-1-2-4-8-6/h1-4,9H,5H2,(H2,10,11,12)(H2,13,14,15)
• InChIKey: XXNASZAYANFLID-UHFFFAOYSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Risedronate Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:

• Risedronate Sodium
• Risedronate Sodium Tablets
• Risedronate Sodium Delayed-Release Tablets

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08
• Signalwort: Danger
• H-Sätze: H317,H334
• P-Sätze: P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313
• Gefahreneinstufungen: Resp. Sens. 1 - Skin Sens. 1
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable